Glycogen synthase kinase 3β inhibition sensitizes human glioblastoma cells to temozolomide by affecting O6-methylguanine DNA methyltransferase promoter methylation via c-Myc signaling

ピコイリア
Pyko Ilya Vassilyevich

Open PDF

Open link

Publication date

September 2013

DOI

10.1093/carcin/bgt182

Publisher

Oxford University Press (OUP)

Abstract

13301甲第3924号博士（医学）金沢大学博士論文本文Full 以下に掲載：Carcinogenesis 34(10) pp.2206-2217 2013. Oxford University Press. 共著者：Ilya V. Pyko, Mitsutoshi Nakada, Hemragul Sabit, Lei Teng, Natsuki Furuyama, Yutaka Hayashi, Kazuyuki Kawakami, Toshinari Minamoto, Аliaksandr S. Fedulau and Jun-ichiro Hamad

Extracted data

We use cookies to provide a better user experience.

Data Protection

Glycogen synthase kinase 3β inhibition sensitizes human glioblastoma cells to temozolomide by affecting O6-methylguanine DNA methyltransferase promoter methylation via c-Myc signaling

Abstract

Extracted data

Glycogen synthase kinase 3β inhibition sensitizes human glioblastoma cells to temozolomide by affecting O6-methylguanine DNA methyltransferase promoter methylation via c-Myc signaling

Abstract

Extracted data

Related items

Related items